Core Viewpoint - The SynBioCon 2025 conference will focus on the integration of AI with biomanufacturing, green chemicals and new materials, future food, and future agriculture, aiming to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan period [1]. Group 1: Conference Overview - The conference will take place from August 20 to 22, 2025, in Ningbo, Zhejiang [1]. - It aims to promote the transfer and transformation of scientific and technological achievements, product scaling, and talent acquisition in the biomanufacturing sector [1]. Group 2: Organizers and Support Units - Organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and co-organized by several academic and research institutions [2]. - Supported by various associations and alliances, including the Chinese Society of Biotechnology and the Zhejiang Synthetic Biology Industry Technology Alliance [2]. Group 3: Expert Guests - Notable experts include Zhang Xian'en, Dean of the School of Synthetic Biology at Shenzhen University of Technology, and other prominent figures in the field of biomanufacturing [4][5][6]. - The conference will feature presentations from experts on topics such as the construction of efficient cell factories and the biomanufacturing of key industrial monomers [8][11][30]. Group 4: Conference Agenda - The agenda includes a series of forums and discussions on topics like green chemicals, AI in biomanufacturing, and future food and agriculture [36][37]. - Activities will include a high-level roundtable on biomanufacturing and a youth forum to showcase innovative achievements in the industry [36].

Core Insights - The article highlights the ongoing development and innovation in the synthetic biology and biomanufacturing sectors in China, with a focus on Guangdong province, particularly Guangzhou and Shenzhen, which are leading in policy support and innovation outcomes [2][3]. Summary by Sections Industry Overview - Guangdong province's biomanufacturing industry is valued at approximately 1.3 trillion yuan, ranking third nationally, with plans to elevate the industry to a trillion-yuan scale through the "Action Plan for Accelerating the Construction of Biomanufacturing Industry Innovation High Ground" [2]. - Shenzhen has positioned synthetic biology as one of its "20+8" future industries, establishing a comprehensive support system for biomanufacturing, including a major synthetic biology infrastructure and a national innovation center [2]. Company Rankings - SynBioCon has released the "Top 500 Representative Enterprises in Biomanufacturing (Guangdong Edition)," featuring 76 companies recognized for their competitiveness based on team, core products, and diverse possibilities [3]. Upcoming Events - The "China Biomanufacturing Industry Map (2025)" will be published in August 2025, with a focus on 500 representative enterprises in biomanufacturing [1]. - The Fourth Synthetic Biology and Green Biomanufacturing Conference will be held from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and biomanufacturing, green chemicals, new materials, future food, and agriculture [12][14].

Core Viewpoint - The article highlights the journey and contributions of Qi Qingsheng in the field of microbiology, emphasizing his role in synthetic biology, biomanufacturing, and resource recycling, as well as his commitment to education and nurturing future talents in the discipline [1][9][19]. Group 1: Academic Journey - Qi Qingsheng's interest in microbiology was sparked by a chance encounter with microbiologist Wang Zunong, leading him to excel in the field at Shandong University [3][4]. - He faced challenges during his undergraduate studies due to the extensive memorization required in microbiology, which later helped him guide students in overcoming academic hurdles [5]. - After completing his master's degree in 1992, he joined the team to establish the National Key Laboratory of Microbial Technology, overcoming initial hardships to lay a solid foundation for future research [6][9]. Group 2: Research Contributions - Upon returning from Germany with a PhD in molecular microbiology, Qi recognized the potential of synthetic biology in China and began promoting its application domestically in 2008 [9][11]. - He led significant projects focusing on the biodegradation of waste plastics, securing 15 million in funding for international collaboration in 2018, demonstrating the integration of synthetic biology with circular economy principles [11][19]. Group 3: Educational Impact - Qi has mentored over 160 students, emphasizing the importance of mutual effort between mentors and students in achieving academic success [13][14]. - He encourages students to engage in research projects to enhance their practical skills and understanding of theoretical concepts, advocating for a balance between hard work and awareness of scientific trends [15][19]. Group 4: Future of Microbiology - Qi expresses confidence in the broad applications of microbiology across various sectors, including food fermentation, environmental protection, and biomanufacturing, urging young scholars to explore unknown fields [18][19]. - He stresses the need for microbiology to align with national strategic demands and to bridge the gap between fundamental research and industrial application [19][21].

Core Viewpoint - Tianjin Hesheng Biotechnology Co., Ltd. has completed a multi-million Pre-A round financing, which will accelerate its technological innovation in the synthetic biology field and lead new trends in health and nutrition solutions [1][2]. Group 1: Company Overview - Established in August 2023, Hesheng Biotechnology is a key technology transfer enterprise of Nankai University, gathering a leading research team in synthetic biology with nearly 30 years of experience [2]. - The company has developed a "DBTL" (Design-Build-Test-Learn) technical platform, utilizing proprietary gene element databases and self-developed AI algorithms to create high-productivity microbial strains [2]. - Hesheng Biotechnology has a comprehensive technical coverage from product research and development to downstream applications, focusing on probiotics, functional foods, and medical foods [2]. Group 2: Key Product Focus - Human Milk Oligosaccharides (HMOs) - The core technology for Hesheng Biotechnology's HMO products originates from the National Key Basic Research Program (973 Program), with the team first synthesizing HMOs in 2016 and obtaining invention patents for industrial strains [3]. - The company has developed several industrial strain construction technologies for HMOs, including 2'-FL, 3-FL, and others, with a product purity of 98.98%, significantly exceeding domestic and international quality standards [3][4]. Group 3: Research and Application - Hesheng Biotechnology is committed to independent innovation and has initiated research on the functional applications of HMOs, including their role in immune balance and disease intervention [4].

Core Viewpoint - The article discusses the current state and future potential of bioplastics, highlighting the advancements in microbial production of plastic monomers and the challenges faced in achieving industrial-scale production [1][2]. Group 1: Bioplastics Market Overview - The representative bioplastics in the market include PBAT, PLA, PBS, PA, PTT, and PET, which together account for approximately 65% of the total bioplastics market share [1]. - It is projected that by 2025, the annual market share of bioplastics will increase to 18% of the total plastics market [1]. Group 2: Challenges in Microbial Production - The economic feasibility of certain monomers remains low, posing challenges for industrial-scale microbial production [2]. - Key challenges include low raw material utilization efficiency, poor monomer synthesis efficiency due to complex microbial metabolic networks, and weak environmental tolerance of microorganisms during fermentation [2]. Group 3: Technological Developments - A research team led by Professor Liu Liming and Associate Researcher Gao Cong from Jiangnan University has developed key technologies for the high-yield production of plastic monomers such as 1,3-propanediol, succinic acid, and pentamethylenediamine [3]. Group 4: Upcoming Events - The SynBioCon 2025 conference will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing, as well as advancements in green chemistry and new materials [10][11].

Project Overview - The project is named "Annual Production of 855 Tons of Green Active Raw Materials" and is initiated by Shandong Yunluo Biotechnology Co., Ltd. [2] - The total estimated investment for the project is 100 million yuan, with 7.5% allocated for environmental protection, amounting to 7.5 million yuan [2]. - The construction period is planned for one year, and the project will utilize existing factory buildings while acquiring new production equipment [2]. Production Capacity - Upon reaching full production capacity, the project is expected to produce 1 ton of probiotics, 5 tons of ergothioneine, 126 tons of ectoine, 250 tons of hydroxypropyl tetrahydropyran triol (Bosein), and 473 tons of gluconic acid annually [2][3]. - The products will be sold externally and adhere to the company's quality standards [3]. Company Background - Shandong Yunluo Biotechnology Co., Ltd. is a wholly-owned subsidiary of Shanghai Yunluo Biotechnology Co., Ltd. [3]. - The company focuses on synthetic biology, specializing in enzyme gene mining, directed enzyme modification, cell factory construction, biological fermentation, and enzyme catalysis [3]. Industry Event - The Fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang [5]. - The conference will focus on the integration of AI and biological manufacturing, as well as the industrialization progress and opportunities in green chemistry, new materials, future food, and agriculture [5]. - Various stakeholders, including international enterprises, industry experts, and government representatives, will participate to explore trends in biological manufacturing and innovation [5].

Core Insights - The establishment of Hefei Ian Biotechnology Co., Ltd. with a registered capital of 10 million yuan focuses on the manufacturing and research of bio-based materials, indicating a growing interest in sustainable materials in the industry [1][3]. Group 1: Company Overview - Enhe Biotechnology, founded in 2019 and headquartered in Hangzhou, has become a prominent player in the capital market, utilizing a high-throughput experimental platform to optimize biological engineering for industrial applications [3][4]. - The company has completed over $145 million in financing by 2025 and was recognized as one of the "50 Smartest Companies" by MIT Technology Review in 2020 [4]. Group 2: Strategic Collaborations - In May 2023, a strategic partnership was formed between domestic beauty giant Proya and Enhe Biotechnology, focusing on AI-driven bio-manufacturing technologies for cosmetic ingredient development [5][7]. - This collaboration aims to innovate in the realm of bioactive ingredients for cosmetics, promoting a shift towards efficiency, safety, and sustainability in the beauty industry [7]. Group 3: Industry Movements - Yili Group, a leading dairy company in China, is venturing into synthetic biology, seeking investment opportunities in early-stage innovative companies within the health food sector [8][10]. - Yili has established a venture capital fund with a total subscription amount of 20 million yuan, focusing on high-tech innovations in the health sector, particularly in food science and life sciences [10][11]. Group 4: Sustainability Initiatives - Yili has been actively pursuing sustainable development, as evidenced by its collaboration with Xampla to test a new plant-based packaging material aimed at preserving nutrients in dairy products [12][15]. - The company emphasizes a commitment to a sustainable future while achieving steady business growth [15]. Group 5: Upcoming Events - The 2025 Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [17][19]. - The conference will feature various activities, including forums, discussions, and showcases of synthetic biology innovations [17][18].

Core Insights - The core viewpoint of the article emphasizes the growth potential of China's biomanufacturing industry, projecting a scale of 1.01 trillion yuan in 2024, with a year-on-year growth of 15.4%, and an expected scale exceeding 2.5 trillion yuan by 2030, reflecting a compound annual growth rate of 16.8% [1]. Industry Overview - The biomanufacturing industry in China is set to reach a scale of 1.01 trillion yuan in 2024, marking a 15.4% increase from the previous year [1]. - By 2030, the industry is anticipated to surpass 2.5 trillion yuan, with a compound annual growth rate of 16.8% [1]. Event Information - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynbioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, where the "China Synthetic Biology Industry Distribution Map (2025 Edition)" will be released [9]. - The conference will focus on five key areas: AI + Biomanufacturing, Green Chemistry and New Materials, Future Food, Future Agriculture, and Beauty Raw Materials, aiming to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan [9]. Participation and Benefits - Representatives attending the conference can receive a free copy of the industry map, valued at 499 yuan [6]. - Biomanufacturing companies that qualify can apply to be listed on the industry map and gain access to the "Global Bio-based and Biomanufacturing Industry Service Platform" [6][9].

Core Viewpoint - The SynBioCon 2025 conference will focus on the integration of AI with biomanufacturing, green chemicals and new materials, future food, and future agriculture, aiming to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan period [1]. Group 1: Conference Overview - The conference will take place from August 20 to 22, 2025, in Ningbo, Zhejiang [1]. - It aims to promote the transfer and transformation of scientific and technological achievements, product scaling, and talent acquisition in the biomanufacturing sector [1]. Group 2: Organizers and Supporters - Organized by Ningbo Detaizhongyan Information Technology Co., Ltd. (DT New Materials) and co-organized by several academic and research institutions [2]. - Supported by various associations and alliances, including the Chinese Society of Biotechnology and the Zhejiang Synthetic Biology Industry Technology Alliance [2]. Group 3: Expert Guests - Notable experts include Zhang Xian'en, Dean of the School of Synthetic Biology at Shenzhen University of Technology, and other prominent figures from various universities and research institutes [4][5][6][7][10][12][14][18][20][22][30][32]. Group 4: Conference Agenda - The agenda includes a series of forums and discussions on topics such as green chemicals, new materials, AI in biomanufacturing, and future food and agriculture [36][37]. - Specific sessions will focus on the construction of efficient cell factories for the production of aromatic compounds and the biomanufacturing of polyamide materials [8][11].

Core Viewpoint - The announcement by the National Center for Food Safety Risk Assessment regarding the inclusion of alginate oligosaccharides (AOS) as a new food ingredient marks a significant transition from agricultural and pharmaceutical auxiliary materials to mainstream food applications in China [2][4]. Group 1: New Food Ingredient Approval - On July 10, the National Center for Food Safety Risk Assessment released a notice that AOS and six other new food materials have passed technical review and are now in the public consultation phase, which will end on August 9, 2025 [1][2]. - This is the first time AOS has been included in the management of new food materials in China, indicating its potential for broader consumer use [2]. Group 2: Characteristics and Production of AOS - AOS is a functional oligosaccharide derived from alginate through specific degradation reactions, which can be achieved using various methods such as acid, enzyme, or oxidative degradation [5]. - The enzymes responsible for alginate degradation are primarily sourced from marine algae, marine invertebrates, marine fungi, marine bacteria, and terrestrial bacteria [5][7]. Group 3: Upcoming Industry Event - The Fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the intersection of AI and bio-manufacturing, as well as advancements in green chemistry, new materials, future food, and agriculture [8][11]. - The conference aims to gather international leading companies, industry experts, and various stakeholders to explore trends in bio-manufacturing and the impact of innovative technologies on the industry [8].